Review Article
Safety, Effectiveness, and Cost Effectiveness of Metabolic Surgery in the Treatment of Type 2 Diabetes Mellitus
Table 2
Summary results for the base-case analysis [
13].
| | 35-year time horizon | Bariatric surgery | Medical management | Difference |
| | Life expectancy, y | 11.536 (0.424) | 10.870 (0.187) | 0.6666 (0.460) | | Quality-adjusted life expectancy, y | 6.782 (0.479) | 5.883 (0.105) | 0.8999 (0.493) | | Total costs (2007, dollars) | 83,482 (3191) | 63,722 (2296) | 19,760 (3861) | | Management | 9117 | 11,621 | −2504 | | Cardiovascular disease | 34,811 | 37,824 | −3013 | | Renal | 3592 | 4539 | −947 | | Eye | 3769 | 3963 | −194 | | Ulcer/neuropathy/amputation | 5915 | 5776 | 139 | | Surgery | 23,131 | 0 | 23,131 | | Incremental cost per life-year gained (2007, dollars) | — | — | 29,676 | | Incremental cost per QALY gained (2007, dollars) | — | — | 21,973 |
|
|
